New Stock News | New Chinese Medicine Hong Kong Stock IPO Prospectus Invalid

According to the Wise Finance APP, the Hong Kong stock prospectus submitted by Guangzhou Xinji Pharmaceutical Co., Ltd. (referred to as "Xinji Pharmaceutical") on December 24, 2025, will expire after 6 months on June 24, 2026. When submitting the application, Guotai Haitong was its exclusive sponsor.